Literature DB >> 15097959

Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002.

K Wade Foster1, Mahmoud A Ghannoum, Boni E Elewski.   

Abstract

BACKGROUND: Cutaneous fungal infections are common in the United States, and causative organisms include dermatophytes, yeasts, and nondermatophyte molds. These organisms are in constant competition for their particular environmental niche, often resulting in the emergence of one or more predominant pathogens and displacement of other less competitive species. Changes in the incidence of fungal pathogens can be followed from laboratory culture results of infected cutaneous tissues over time. These data can be used to ascertain past and present trends in incidence, predict increases in antifungal resistance and the adequacy of our current pharmacologic repertoire, and provide insight into future developments.
OBJECTIVE: This study identifies epidemiologic trends and the predominant organisms causing superficial fungal infections in the United States.
METHODS: A total of 15,381 specimens were collected from clinically suspected tinea corporis, tinea cruris, tinea capitis, tinea faciei, tinea pedis, tinea manuum, and finger and toe onychomycosis from 1999 through 2002. Specimens were submitted to the Center for Medical Mycology in Cleveland, Ohio, for fungal culture and identification, and the incidence of each species was calculated.
RESULTS: Dermatophytes remain the most commonly isolated fungal organisms except from clinically suspected finger onychomycosis, in which case Candida species comprise >70% of isolates. Trichophyton rubrum remains the most prevalent fungal pathogen, and increased incidence of this species was observed in finger and toe onychomycosis, tinea corporis and tinea cruris, tinea manuum, and tinea pedis. As the causal agent of tinea capitis, T tonsurans continues to increase in incidence, achieving near exclusionary proportions in the United States.
CONCLUSION: Consideration of the current epidemiologic trends in the incidence of cutaneous fungal pathogens is of key importance to investigational efforts, diagnosis, and treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15097959     DOI: 10.1016/s0190-9622(03)02117-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  35 in total

1.  Dermatophyte identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Elitza S Theel; Leslie Hall; Jayawant Mandrekar; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  Epidemiology of dermatophytoses in a rural community in Eastern Nigeria and review of literature from Africa.

Authors:  Ada C Ngwogu; Tosanwumi Vincent Otokunefor
Journal:  Mycopathologia       Date:  2007-07-27       Impact factor: 2.574

3.  Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis.

Authors:  Hiroyasu Koga; Yasuko Nanjoh; Hideo Kaneda; Hideyo Yamaguchi; Ryoji Tsuboi
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 4.  National athletic trainers' association position statement: skin diseases.

Authors:  Steven M Zinder; Rodney S W Basler; Jack Foley; Chris Scarlata; David B Vasily
Journal:  J Athl Train       Date:  2010 Jul-Aug       Impact factor: 2.860

5.  Activity of TDT 067 (terbinafine in Transfersome) against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrations.

Authors:  Mahmoud Ghannoum; Nancy Isham; Jacqueline Herbert; William Henry; Sam Yurdakul
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

Review 6.  Skin conditions of baseball, cricket, and softball players.

Authors:  Joshua A Farhadian; Brook E Tlougan; Brian B Adams; Jonathan S Leventhal; Miguel R Sanchez
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

7.  Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.

Authors:  William J Jo Siu; Yoshiyuki Tatsumi; Hisato Senda; Radhakrishnan Pillai; Takashi Nakamura; Daisuke Sone; Annette Fothergill
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

8.  Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections.

Authors:  Nathan Stasko; Kimberly McHale; Stanley J Hollenbach; Megan Martin; Ryan Doxey
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 9.  The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

Review 10.  Updates on the epidemiology of dermatophyte infections.

Authors:  Claus Seebacher; Jean-Philippe Bouchara; Bernard Mignon
Journal:  Mycopathologia       Date:  2008-05-14       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.